Markets Hold Steady Ahead of Warsh's FOMC Debut as Samsung-Hyundai Boston Dynamics Stake Talk Surfaces

The day's biggest talking point was a report that Samsung Electronics is considering acquiring Hyundai Motor Group's stake in Boston Dynamics. The trigger is SoftBank's call-option expiration this Saturday on its 10% Boston Dynamics stake — a decision SoftBank must make within the week. Should SoftBank decline to exercise, that stake could come up for sale, with Samsung floated as a likely buyer. The speculation gained credibility after Samsung's CFO said earlier this year the company was reviewing various M&A and equity investment opportunities in future growth areas including robotics.

Underlying the interest is Samsung's enormous cash pile, estimated to exceed 150 trillion won by mid-year — reportedly surpassing even Nvidia's cash holdings. Analysts argue how Samsung deploys this cash is critical, since Korea's chronic corporate undervaluation is often attributed to low return on equity from firms sitting on idle cash rather than deploying it productively. Building new fabs risks repeating past chip price wars through oversupply, whereas acquiring equity stakes in new businesses offers potentially higher returns with less controversy over capacity competition.

A second dimension is the potential for domestic corporate cooperation. Korean robotics players must compete globally against Chinese firms and Tesla, a fight Hyundai alone may struggle to win. Should Samsung and Hyundai join forces in robotics, the combination — especially given Hyundai's existing Nvidia ties — could form one of the world's most formidable robotics alliances. Given persistent criticism that Korean conglomerates cooperate well abroad but rarely with each other domestically, this deal is seen as a possible signal for broader collaboration.

Still, caution is warranted, as the story requires further confirmation. Boston Dynamics is not only central to Hyundai Motor Group's future growth but also intertwined with Chairman Euisun Chung's succession planning. SoftBank holds 10% of Boston Dynamics, with the rest largely held by Hyundai affiliates and Chung personally, whose individual stake reportedly stands at 23%. Because Hyundai's group control would remain secure even if Chung sold part of his personal stake post-listing, proceeds from such a sale have long been floated as a potential source of funds for inheritance and gift taxes tied to succession.

Against this backdrop, any tie-up between historic rivals Samsung and Hyundai via Boston Dynamics would be remarkable in Korean corporate history. Given Samsung has no obvious reason to chase a mere 10% stake for capital gains alone, speculation centers on a broader play — supplying cameras, semiconductors, batteries and other components into the robotics venture. While the report still requires verification, its potential impact if confirmed would be substantial.

As Samsung Electronics and SK Hynix pulled back, biotech, shipbuilding and defense stocks benefited from the rotation. DND Pharmatech surged about 20% on news it will jointly develop next-generation AI-based peptide drugs with LG AI Research, while Olix gained about 15% on pipeline-related news. ABL Bio jumped roughly 14% after its cancer drug received FDA fast-track designation, and LNC Bio rose similarly on news its skin-booster product showed hair-loss treatment effects. Other biotech names including Alteogen, Kolon TissueGene and Voronoi also rallied, driving the KOSDAQ's overall gains.

Defense stocks strengthened notably, with analysts framing the war's end as the true beginning of defense orders, not their conclusion. The investment case rests on three pillars: geopolitics, earnings and valuation. As the U.S. reallocates military resources toward the Asia-Pacific, allies including in Europe are raising defense budgets, and estimates suggest replenishing missile stockpiles depleted in the recent Middle East conflict could take about four years — fueling order expectations. Earnings have also improved markedly, with exports accounting for about 48.5% of combined defense-sector revenue last quarter. Valuations aren't cheap versus global peers, but analysts argue Korean defense stocks' premium is justified.

Hanwha Ocean surged about 8%, at the center of the defense-shipbuilding rotation, after signing a strategic partnership with Canada's Clean Power for an LNG project involving a massive floating offshore LNG production facility handling roughly 12 million tons annually. The deal fueled speculation it could be linked to a halo effect around Hanwha Ocean's pursuit of a Canadian submarine order.

Caution accompanied the optimism, however, as major German media outlets reported their domestic bidder is likely to win the Canadian submarine contract, prompting warnings against overconfident bets before the outcome is confirmed. Separately, LIG Nex1 is reportedly partnering with Germany's Rheinmetall to pursue European and NATO markets, and Hanwha Aerospace increased its stake in Korea Aerospace Industries to 9.97%, becoming its second-largest shareholder — both signs of ongoing consolidation in the defense sector.

Against this backdrop, Samyang Foods rose about 3%, recovering from a recent pullback, while beauty devices, cosmetics and gaming stocks also showed mild rebounds after lagging. The rotation from chip leaders toward domestic defensive and earnings-improving sectors was seen as a healthy sign for the broader market.